Below is an open letter to the U.S. Food and Drug Administration (FDA) in response to a letter sent by the agency to the Federation of State Medical Boards and the National Association of Boards of Pharmacy discouraging the use of ivermectin for treating and preventing COVID. Shannon Glueck, PharmDA Acting Branch ChiefBranch 4Division of […]